Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 105 participants.

Also called NCT02403349

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 105 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02403349
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02403349. Randomized; quadruple masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2015-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol
Acronym
FAVOR
Condition
Blood Pressure
Intervention (Drug)
Fimasartan
Intervention (Drug)
Valsartan
Intervention (Drug)
Atenolol
Lead sponsor
Ajou University School of Medicine (class: other)
Collaborator
Boryung Pharmaceutical Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct02403349
Content hash
61059c18cd14c7774df9ea92677a97c19ecd4ca71198bdb723924308432fb8ab